Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07205198) titled 'A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Shanghai Institute Of Biological Products
Condition:
Advanced Tumors
Intervention:
Drug: SIBP-A10
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: September 30, 2025
Target Sample Size: 160
To know more, visit https://clinicaltrials.gov/study/NCT07205198
Published by HT Digital Content Services wi...